BlackRock Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$7.41M Sell
578,451
-2,180
-0.4% -$27.9K 0.01% 1317
2016
Q3
$7.72M Buy
580,631
+5,481
+1% +$72.9K 0.01% 1175
2016
Q2
$6.3M Buy
575,150
+48,857
+9% +$535K 0.01% 1278
2016
Q1
$4.82M Buy
526,293
+21,467
+4% +$197K 0.01% 1402
2015
Q4
$4.9M Buy
504,826
+2,588
+0.5% +$25.1K 0.01% 1401
2015
Q3
$4.38M Sell
502,238
-5,539
-1% -$48.3K 0.01% 1463
2015
Q2
$5.13M Buy
507,777
+113,469
+29% +$1.15M 0.01% 1478
2015
Q1
$5.28M Buy
394,308
+6,725
+2% +$90.1K 0.01% 1326
2014
Q4
$4.97M Sell
387,583
-3,870
-1% -$49.7K 0.01% 1359
2014
Q3
$4.25M Buy
391,453
+2,279
+0.6% +$24.7K 0.01% 1449
2014
Q2
$5M Buy
389,174
+38,502
+11% +$494K 0.01% 1389
2014
Q1
$3.62M Buy
350,672
+45,656
+15% +$471K 0.01% 1612
2013
Q4
$2.97M Sell
305,016
-7,149
-2% -$69.5K ﹤0.01% 1719
2013
Q3
$3.1M Buy
312,165
+19,165
+7% +$190K 0.01% 1616
2013
Q2
$2.44M Buy
+293,000
New +$2.44M ﹤0.01% 1711